Synergistic effects of Clostridium perfringens enterotoxin and beta toxin in rabbit small intestinal loops

Infection and Immunity

Volumn 82, Issue 7, 2014, Pages 2958-2970

  Ma, Menglin ^a   Gurjar, Abhijit ^a,c   Theoret, James R ^a   Garcia, Jorge P ^b   Beingesser, Juliann ^b   Freedman, John C ^a   Fisher, Derek J ^a,d   McClane, Bruce A ^a   Uzal, Francisco A ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MERCK ANIMAL HEALTH   (United States)

^d SOUTHERN ILLINOIS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOSTRIDIUM PERFRINGENS ENTEROTOXIN; CLOSTRIDIUM TOXIN; ENTEROTOXIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL LYSATE; CLOSTRIDIUM PERFRINGENS; CONTROLLED STUDY; CULTURE MEDIUM; FEMALE; GENE MUTATION; INTESTINE LOOP; MALE; MUTANT; NONHUMAN; PRIORITY JOURNAL; RABBIT; SPOROGENESIS; SUPERNATANT; WESTERN BLOTTING; WILD TYPE;

ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL TOXINS; ENTEROTOXINS; FEMALE; GENE EXPRESSION REGULATION, BACTERIAL; INTESTINE, SMALL; MALE; MUTATION; RABBITS;

EID: 84903130691     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01848-14     Document Type: Article

References (37)

1. McClane BA, Uzal FA, Miyakawa MF, Lyerly D, Wilkins TD. 2006. The enterotoxic clostridia, p 688-752. In Dworkin M, Falkow S, Rosenburg E, Schleifer H, Stackebrandt E (ed), The prokaryotes, 3rd ed. Springer Press, New York, NY.
2. McClane BA, Lyerly DM, Wilkins TD. 2006. Enterotoxic clostridia: Clostridium perfringens type A and Clostridium difficile, p 703-714. In Fischetti VA, Novick RP, Ferretti JJ, Portnoy DA, Rood J (ed), Gram-positive pathogens, 3rd ed. ASM Press, Washington, DC.
3. Li J, Adams V, Bannam TL, Miyamoto K, Garcia JP, Uzal FA, Rood JI, McClane BA. 2013. Toxin plasmids of Clostridium perfringens. Microbiol. Mol. Biol. Rev. 77:208-233. http://dx.doi.org/10.1128/MMBR.00062-12.
4. Songer JG. 1996. Clostridial enteric diseases of domestic animals. Clin. Microbiol. Rev. 9:216-234.
5. Uzal FA, McClane BA. 2011. Recent progress in understanding the pathogenesis of Clostridium perfringens type C infections. Vet. Microbiol. 153:37-43. http://dx.doi.org/10.1016/j.vetmic.2011.02.048.
6. Lawrence GW. 1997. The pathogenesis of enteritis necroticans, p 198-207. In Rood JI, McClane BA, Songer JG, Titball RW (ed), The clostridia: molecular genetics and pathogenesis. Academic Press, London, United Kingdom.
7. Johnson S, Gerding DN. 1997. Enterotoxemic infections, p 117-140. In Rood JI, McClane BA, Songer JG, Titball RW (ed), The clostridia: molecular biology and pathogenesis. Academic Press, London, United Kingdom.
8. Walker PD. 1985. Pig-bel, p 93-116. In Borriello SP (ed), Clostridia in gastrointestinal disease. CRC Press, Boca Raton, FL.
9. Petrillo TM, Beck-Sague CM, Songer JG, Abramowsky C, Fortenberry JD, Meacham L, Dean AG, Lee H, Bueschel DM, Nesheim SR. 2000. Enteritis necroticans (pigbel) in a diabetic child. N. Engl. J. Med. 342: 1250-1253. http://dx.doi.org/10.1056/NEJM200004273421704.
10. Zeissler J, Rassfeld-Sternberg L. 1949. Enteritis necroticans due to Clostridium welchii type F. Br. Med. J. 1:267-269. http://dx.doi.org/10.1136/bmj.1.4597.267.
11. Ma M, Li J, McClane B. 2012. Genotypic and phenotypic characterization of Clostridium perfringens isolates from Darmbrand cases in post-World War II Germany. Infect. Immun. 80:4354-4363. http://dx.doi.org/10.1128/IAI.00818-12.
12. Sayeed S, Uzal FA, Fisher DJ, Saputo J, Vidal JE, Chen Y, Gupta P, Rood JI, McClane BA. 2008. Beta toxin is essential for the intestinal virulence of Clostridium perfringens type C disease isolate CN3685 in a rabbit ileal loop model. Mol. Microbiol. 67:15-30. http://dx.doi.org/10.1111/j.1365-2958.2007.06007.x.
13. Sarker MR, Carman RJ, McClane BA. 1999. Inactivation of the gene (cpe) encoding Clostridium perfringens enterotoxin eliminates the ability of two cpe-positive C. perfringens type A human gastrointestinal disease isolates to affect rabbit ileal loops. Mol. Microbiol. 33:946-958. http://dx.doi.org/10.1046/j.1365-2958.1999.01534.x.
14. Fisher DJ, Fernandez-Miyakawa ME, Sayeed S, Poon R, Adams V, Rood JI, Uzal FA, McClane BA. 2006. Dissecting the contributions of Clostridium perfringens type C toxins to lethality in the mouse intravenous injection model. Infect. Immun. 74:5200-5210. http://dx.doi.org/10.1128/IAI.00534-06.
15. Skjelkvale R, Duncan CL. 1975. Enterotoxin formation by different toxigenic types of Clostridium perfringens. Infect. Immun. 11:563-575.
16. Skjelkvale R, Duncan CL. 1975. Characterization of enterotoxin purified from Clostridium perfringens type C. Infect. Immun. 11:1061-1068.
17. Li J, Miyamoto K, Sayeed S, McClane BA. 2010. Organization of the cpe locus in CPE-positive Clostridium perfringens type C and D isolates. PLoS One 5:e10932. http://dx.doi.org/10.1371/journal.pone.0010932.
18. McDonel JL, McClane BA. 1988. Production, purification and assay of Clostridium perfringens enterotoxin. Method. Enzymol. 165:94-103. http://dx.doi.org/10.1016/S0076-6879(88)65018-X.
19. McClane BA, Robertson SL, Li J. 2013. Clostridium perfringens, p 465-489. In Doyle MP, Buchanan RL (ed), Food microbiology: fundamentals and frontiers, 4th ed. ASM Press, Washington, DC.
20. Li J, Chen J, Vidal JE, McClane BA. 2011. The Agr-like quorum-sensing system regulates sporulation and production of enterotoxin and beta2 toxin by Clostridium perfringens type A non-food-borne human gastrointestinal disease strain F5603. Infect. Immun. 79:2451-2459. http://dx.doi.org/10.1128/IAI.00169-11.
21. Vidal JE, McClane BA, Saputo J, Parker J, Uzal FA. 2008. Effects of Clostridium perfringens beta-toxin on the rabbit small intestine and colon. Infect. Immun. 76:4396-4404. http://dx.doi.org/10.1128/IAI.00547-08.
22. Chen Y, McClane BA, Fisher DJ, Rood JI, Gupta P. 2005. Construction of an alpha toxin gene knockout mutant of Clostridium perfringens type A by use of a mobile group II intron. Appl. Environ. Microbiol. 71:7542-7547. http://dx.doi.org/10.1128/AEM.71.11.7542-7547.2005.
23. Vidal JE, Ma M, Saputo J, Garcia J, Uzal FA, McClane BA. 2012. Evidence that the Agr-like quorum sensing system regulates the toxin production, cytotoxicity and pathogenicity of Clostridium perfringens type C isolate CN3685. Mol. Microbiol. 83:179-194. http://dx.doi.org/10.1111/j.1365-2958.2011.07925.x.
24. Smedley JG, III, Saputo J, Parker JC, Fernandez-Miyakawa ME, Robertson SL, McClane BA, Uzal FA. 2008. Noncytotoxic Clostridium perfringens enterotoxin (CPE) variants localize CPE intestinal binding and demonstrate a relationship between CPE-induced cytotoxicity and enterotoxicity. Infect. Immun. 76:3793-3800. http://dx.doi.org/10.1128/IAI.00460-08.
25. Bartholomew BA, Stringer MF, Watson GN, Gilbert RJ. 1985. Development and application of an enzyme-linked immunosorbent assay for Clostridium perfringens type A enterotoxin. J. Clin. Pathol. 38:222-228. http://dx.doi.org/10.1136/jcp.38.2.222.
26. Macias Rioseco M, Beingesser J, Uzal FA. 2012. Freezing or adding trypsin inhibitor to equine intestinal contents extends the lifespan of Clostridium perfringens beta toxin for diagnostic purposes. Anaerobe 18:357-360. http://dx.doi.org/10.1016/j.anaerobe.2012.03.003.
27. Awad MM, Ellemor DM, Boyd RL, Emmins JJ, Rood JI. 2001. Synergistic effects of alpha-toxin and perfringolysin O in Clostridium perfringens-mediated gas gangrene. Infect. Immun. 69:7904-7910. http://dx.doi.org/10.1128/IAI.69.12.7904-7910.2001.
28. Verherstraeten S, Goossens E, Valgaeren B, Pardon B, Timbermont L, Vermeulen K, Schauvliege S, Haesebrouck F, Ducatella R, Deprez P, Van Immerseel F. 2013. The synergistic necrohemorrhagic action of Clostridium perfringens perfringolysin and alpha toxin in the bovine intestine and against bovine endothelial cells. Vet. Res. 44:45. http://dx.doi.org/10.1186/1297-9716-44-45.
29. Uzal FA, Saputo J, Sayeed S, Vidal JE, Fisher DJ, Poon R, Adams V, Fernandez-Miyakawa ME, Rood JI, McClane BA. 2009. Development and application of new mouse models to study the pathogenesis of Clostridium perfringens type C enterotoxemias. Infect. Immun. 77:5291-5299. http://dx.doi.org/10.1128/IAI.00825-09.
30. Garcia JP, Beingesser J, Fisher DJ, Sayeed S, McClane BA, Posthaus H, Uzal FA. 2012. The effect of Clostridium perfringens type C strain CN3685 and its isogenic beta toxin null mutant in goats. Vet. Microbiol. 157:412-419. http://dx.doi.org/10.1016/j.vetmic.2012.01.005.
31. Chakrabarti G, McClane BA. 2005. The importance of calcium influx, calpain, and calmodulin for the activation of CaCo-2 cell death pathways by Clostridium perfringens enterotoxin. Cell. Microbiol. 7:129-146. http://dx.doi.org/10.1111/j.1462-5822.2004.00442.x.
32. Chakrabarti G, Zhou X, McClane BA. 2003. Death pathways activated in CaCo-2 cells by Clostridium perfringens enterotoxin. Infect. Immun. 71: 4260-4270. http://dx.doi.org/10.1128/IAI.71.8.4260-4270.2003.
33. Autheman D, Wyder M, Popoff M, D'Herde K, Christen S, Posthaus H. 2013. Clostridium perfringens beta-toxin induces necrostatin-inhibitable, calpain-dependent necrosis in primary porcine endothelial cells. PLoS One 8:e64644. http://dx.doi.org/10.1371/journal.pone.0064644.
34. Steinthorsdottir V, Halldorsson H, Andresson OS. 2000. Clostridium perfringens beta-toxin forms multimeric transmembrane pores in human endothelial cells. Microb. Pathog. 28:45-50. http://dx.doi.org/10.1006/mpat.1999.0323.
35. McClane BA, Wnek AP, Hulkower KI, Hanna PC. 1988. Divalent cation involvement in the action of Clostridium perfringens type A enterotoxin. J. Biol. Chem. 263:2423-2435.
36. Miclard J, Jaggi M, Sutter E, Wyder M, Grabscheid B, Posthaus H. 2009. Clostridium perfringens beta-toxin targets endothelial cells in necrotizing enteritis in piglets. Vet. Microbiol. 137:320-325. http://dx.doi.org/10.1016/j.vetmic.2009.01.025.
37. Garcia JP, Adams V, Beingesser J, Hughes ML, Poon R, Lyras D, Hill A, McClane BA, Rood JI, Uzal FA. 2013. Epsilon toxin is essential for the virulence of Clostridium perfringens type D infection in sheep, goats and mice. Infect. Immun. 81:2405-2414. http://dx.doi.org/10.1128/IAI.00238-13.